Vericel Reports Record Third Quarter Revenues, Net Income and Operating Cash Flow
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Vericel (VCEL) Tops Q3 EPS by 9c, Revenues Beta; Raises FY19 Revenue Outlook
November 5, 2019 8:05 AM ESTVericel (NASDAQ: VCEL) reported Q3 EPS of $0.07, $0.09 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $30.5 million versus the consensus estimate of $26.84 million.
Third Quarter 2019 Financial Highlights
Total net product revenues increased 36% to $30.5 million compared to $22.5 million in the third quarter of 2018, marking the tenth consecutive quarter with record revenues for the reported quarter;MACI® net revenue of $20.6 million and Epicel® net product revenue of $9.9 million, the highest quarterly Epicel revenue in history;Gross... More